Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:SNX
NYSE:SNXElectronic

TD SYNNEX Expands Cybersecurity Story With Aura Identity BYOD Partnership

TD SYNNEX (NYSE:SNX) has partnered with Aura Business to distribute identity-centric BYOD security solutions across its reseller and MSP network. The collaboration focuses on securing remote and hybrid work setups while maintaining end user privacy. The Aura Business platform will be offered to TD SYNNEX partners as part of its broader cybersecurity and endpoint protection portfolio. For investors tracking TD SYNNEX at a share price of $231.75, this agreement comes during a period of strong...
NYSE:IFF
NYSE:IFFChemicals

IFF Vanilla Hub In Madagascar Ties Origin Sourcing To Undervalued Stock Narrative

IFF (NYSE:IFF) has opened a Vanilla Innovation Center in Madagascar, a key origin for natural vanilla. The facility is intended to focus on origin-based product development, sustainability, and local supply chain support. The center links Madagascar vanilla production with IFF’s broader global vanilla network for food, beverage, and fragrance customers. For investors watching NYSE:IFF, this move sits at the intersection of flavor, fragrance, and consumer demand for traceable, natural...
NasdaqCM:EVLV
NasdaqCM:EVLVElectronic

Evolv Technologies Holdings (EVLV) Q1 Loss Challenges Bullish Profitability Narratives

Evolv Technologies Holdings (EVLV) Q1 2026 earnings snapshot Evolv Technologies Holdings (EVLV) opened 2026 with Q1 revenue of US$46.3 million and a basic EPS loss of US$0.03, as investors weigh those figures against a share price of US$6.02. The company reported quarterly revenue of US$32.0 million in Q1 2025 and US$46.3 million in Q1 2026, while basic EPS moved from a loss of US$0.01 in Q1 2025 to a profit of US$0.06 in Q4 2025 before reverting to a loss this quarter. This keeps the...
CNSX:TRUL
CNSX:TRULPharmaceuticals

Trulieve Cannabis (CNSX:TRUL) Is Down 16.4% After Returning To Profitability In Q1 2026 - Has The Bull Case Changed?

Trulieve Cannabis Corp. recently reported first-quarter 2026 results, with sales of US$286.75 million and net income of US$2.41 million, marking a shift from a net loss a year earlier. This return to profitability, alongside the earlier opening of a new Belleview, Florida dispensary, highlights efforts to improve operations while selectively expanding its retail footprint. We’ll now examine how Trulieve’s shift back to profitability in Q1 2026 reshapes its investment narrative and...
NasdaqGS:SND
NasdaqGS:SNDEnergy Services

Smart Sand (SND) Swings To Q1 Loss Challenging Trailing Profitability Narrative

Smart Sand (SND) opened 2026 with Q1 revenue of US$93.1 million and a reported loss per share of US$0.10, as net income excluding extra items came in at a loss of US$3.9 million. Over the past year, the company has seen quarterly revenue move between US$65.6 million and US$93.1 million, while quarterly EPS has ranged from a loss of US$0.62 to a profit of US$0.55, with trailing twelve month EPS at US$0.56. For investors, the shift to positive earnings on a trailing basis, alongside a soft...
HLSE:UPM
HLSE:UPMForestry

UPM QuickStick And ProCycle Launches Put Sustainability Themes In Focus

UPM-Kymmene Oyj (HLSE:UPM) has introduced its QuickStick receipt materials for quick-service restaurants, aimed at faster, more reliable order processing. The QuickStick line includes certified CarbonNeutral options, targeting operators that are focused on climate-responsible ordering and packaging solutions. UPM Adhesive Materials has also launched the ProCycle portfolio, a set of label materials designed to be compatible with established rigid packaging recycling streams. The new ProCycle...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna’s TIME Ranking And Combo Vaccine Approval Reshape Growth Question

Moderna (NasdaqGS:MRNA) ranked no. 1 on TIME's 2026 World's Most Impactful Companies list. The company received European approval for mCOMBRIAX, its first combined flu and COVID vaccine. These developments expand Moderna's recognized societal role and add a new approved product beyond COVID-only vaccines. For investors following Moderna, this recognition and new approval come as the company continues to build around its mRNA platform in vaccines and therapeutics. The flu plus COVID product...
NYSE:HHH
NYSE:HHHReal Estate

Has Howard Hughes Holdings (HHH) Fallen Too Far After Recent Share Price Weakness

Wondering whether Howard Hughes Holdings at around US$64.21 is priced for a rebound or still has more to prove on value? This article focuses squarely on what the current share price might imply. The stock has been fairly flat in the short term, up about 0.1% over the last week and down 0.2% over the last month, while the share price has declined 18.5% year to date and 9.6% over the last year. Those longer term moves sit against a backdrop of ongoing interest in real estate development and...
ASX:PRU
ASX:PRUMetals and Mining

A Look At Perseus Mining (ASX:PRU) Valuation After New Chief Operating Officer Appointment

Perseus Mining (ASX:PRU) has drawn fresh attention after appointing Wade Bickley as Chief Operating Officer, bringing more than 25 years of gold and base metals operational experience across Australia, West Africa and Southern Africa. See our latest analysis for Perseus Mining. The A$5.65 share price has been edging higher in the short term, with a 7 day share price return of 4.05% following the COO announcement, while a 1 year total shareholder return of 73.69% points to strong underlying...
NasdaqGS:ATRO
NasdaqGS:ATROAerospace & Defense

Astronics (ATRO) Q1 EPS Surge Tests Bullish Earnings Growth Narrative

Astronics (ATRO) opened 2026 with Q1 revenue of US$230.6 million and basic EPS of US$1.38, setting a clear marker for how the year is starting after a busy 2025. The company has seen quarterly revenue move from US$205.9 million and EPS of US$0.27 in Q1 2025 to US$230.6 million and EPS of US$1.38 in Q1 2026, while trailing twelve month revenue sits at US$886.8 million and EPS at US$1.28. This puts the spotlight firmly on how much of this uplift is sticking in margins. See our full analysis for...
NasdaqCM:BWEN
NasdaqCM:BWENElectrical

Broadwind (BWEN) Q1 Loss And Earnings Volatility Test Bullish Profitability Narrative

Broadwind (BWEN) opened Q1 2026 with revenue of US$34.1 million and a basic EPS loss of US$0.02, compared with revenue of US$36.8 million and a basic EPS loss of US$0.02 in Q1 2025, while trailing twelve month EPS stood at US$0.22 on revenue of US$155.3 million. Over recent quarters the company has seen revenue move from US$33.6 million in Q4 2024 to US$36.8 million in Q1 2025, then to US$39.2 million in Q2 2025, US$44.2 million in Q3 2025, US$37.7 million in Q4 2025, and US$34.1 million in...
NYSE:AFL
NYSE:AFLInsurance

Aflac Cancer Initiative And New 10% Holder Shape Valuation Debate

Aflac (NYSE:AFL) is spotlighting its Check for Cancer Champion initiative, honoring television personality Adamari López for her cancer awareness advocacy. Separately, a regulatory filing disclosed that J&A Alliance Holdings, linked to Japan Post Holdings, holds a 10% stake in Aflac. Aflac, trading at $115.48, has a track record that includes a 13.6% return over the past year and 130.9% over the past 5 years. Those figures, alongside a 4.8% return year to date, suggest that many investors...